Senior Director, Integrated Planning & Analytics

Job title: Senior Director, Integrated Planning & Analytics

Description

Role Summary

Hybrid Position, requires 2 days onsite/ per week in San Rafael, CA (HQ)

The Senior Director, Integrated Planning & Analytics, leads enterprise planning across demand, supply, inventory, capacity, and financial objectives through Integrated Business Planning (IBP). This role drives profitable growth, operational agility, and patient-centric outcomes across a global rare disease supply network by connecting decisions across Commercial, Clinical, Manufacturing, Quality, Regulatory, Medical Affairs, and Finance.

In a dynamic portfolio shaped by new indications, label expansions, named-patient and compassionate use programs, and clinical-to-commercial transitions, this leader strengthens supply resilience, manages risk, and builds planning capabilities for long-term growth.

As the global process owner for IBP, you will lead forward-looking decision-making across a 24–60-month horizon, including long-range capacity planning and modeling, inventory strategy, and data analytics that support reliable supply and patient access.

Key Responsibilities

• 1. IBP Process Ownership in a Rare Disease Environment

• Own the global IBP framework for rare disease planning, addressing demand variability, small batches, long lead times, and constrained capacity.

• Establish and maintain a consistent IBP cadence (Product Review, Demand Review, Supply Review, Integrated Reconciliation, Executive IBP).

• Own the S&OE (Sales & Operations Execution) process, ensuring near-term demand, supply, and inventory decisions are aligned to the broader IBP framework and escalated appropriately.

• Embed patient-centric planning principles into the IBP cycle (e.g., emergency orders, compassionate use, urgent clinical supply requests).

• Ensure seamless integration of clinical and commercial planning due to overlapping supply sources and shared manufacturing assets.

• 2. Rare Disease Demand, Supply & Inventory Integration

• Oversee reconciliation of commercial, patient, named-patient, early-access, and clinical trial demand signals.

• Ensure supply plans reflect long cycle times, yield variability, cold-chain requirements, and CMO dependencies.

• Lead Inventory Management to define inventory policies, targets, and positioning strategies that minimize expiry while guaranteeing immediate patient access for ultra-low-volume therapies.

• Lead risk-based scenario planning for demand surges (e.g., new diagnoses, outbreaks, compassionate use clusters), supply disruptions, or single-source component issues.

• 3. Cross-Functional Leadership & Governance

• Chair IBP forums across Commercial, Clinical Operations, Technical Operations, Manufacturing, Quality, Regulatory, Finance, and Medical.

• Establish governance and decision rights for trade-offs such as allocation priorities, safety stock strategies, and launch readiness.

• Lead structured decision-making in Executive IBP, ensuring senior leaders have clear scenarios, risks, and recommendations.

• Drive alignment across global, regional, and country planning, accounting for reimbursement and access variability.

4. People Leadership:

• Lead the team of Integrating Planning & Analytics professionals, through strong development and mentoring while creating a culture of high accountability and innovation.

• Ensure there are departmental performance goals and objectives that the team of integrated planners can leverage to develop their respective objectives and provide performance feedback related to business objectives.

• Create a training curriculum to support Integrated Planning & Analytics Team’s development responsibilities.

• Influence teams across the supply chain planning organization to improve their maturity and collaboration through a harmonized integrated planning playbook maximizing optimal support to the planning cycles.

• 5. Financial & Portfolio Integration

• Partner closely with Finance, particularly during AOP/LRP cycles, to embed operational, revenue, COGS, and margin considerations into IBP.

• Integrate portfolio plans including new indications, lifecycle extensions, label expansions, and transitions from clinical supply platforms to scaled commercial supply.

• Support business case development for strategic investments (redundant capacity, alt